uniQure Updates Gene Therapy Program in Treatment of Hemophilia B – Hemophilia News Today
Hemophilia News Today |
uniQure Updates Gene Therapy Program in Treatment of Hemophilia B
Hemophilia News Today Recent advances in gene therapy approaches to treat hemophilia B were recently announced by uniQure. The company achieved “substantial progress in advancing our lead program in hemophilia B,” Matthew Kapusta, CEO of uniQure, said in a press … |
